Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events

Publisher： Karger

E-ISSN： 1662-6575|10|1|296-300

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.1, 2017-04, pp. : 296-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 318-331

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 669-672

Karger

Access to resources Recommend Favorite

Case of respiratory discomfort due to myositis after administration of nivolumab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 1008-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Case of respiratory discomfort due to myositis after administration of nivolumab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 385-2407, Iss. 10, 2015-10 ,pp. : 1008-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduction in Patient Enrollment in the Veterans Health Administration After Media Coverage of Adverse Medical Events

By Weeks William B.   Mills Peter D.  

Joint Commission Journal on Quality and Patient Safety, Vol. 29, Iss. 12, 2003-12 ,pp. : 652-658

Joint Commission Resources

Access to resources Recommend Favorite